Table 2.
Changes in physical parameters, blood pressure (BP), glucose, and lipid metabolism before and after the DialBeticsLite intervention.
| Variables | Baseline measurements (n=48) | Measurements after the intervention (n=48) | P values | |
| Physical parameters | ||||
|
|
Body weight (kg), mean (SD) | 82.6 (13.1) | 79.0 (12.9) | <.001a |
|
|
BMI (kg/m2), median (IQR) | 27.0 (25.5-31.1) | 26.3 (24.1-29.4) | <.001b |
|
|
Waist circumference (cm), median (IQR) | 95.0 (91.0-102.5) | 91.7 (87.0-97.8) | <.001b |
|
|
Visceral fat area (cm2), median (IQR) | 112.0 (90.0-147.0) | 92.0 (68.3-113.8) | <.001b |
| Home BP (n=43) | ||||
|
|
Systolic BP (mm Hg), mean (SD) | 131.8 (14.7) | 126.6 (14.3) | .02a |
|
|
Diastolic BP (mm Hg), mean (SD) | 88.1 (11.5) | 84.7 (10.2) | .02a |
| Glucose and lipid metabolism | ||||
|
|
Fasting plasma glucose (mg/dL), median (IQR) | 90.0 (85.0-95.0) | 87.0 (80.3-93.5) | .01b |
|
|
HbA1cc (%), median (IQR) | 5.6 (5.3-5.8) | 5.4 (5.2-5.6) | <.001b |
|
|
Total cholesterol (mg/dL), median (IQR) | 215.5 (188.0-234.3) | 194.5 (175.5-218.0) | <.001b |
|
|
HDLd cholesterol (mg/dL), mean (SD) | 50.0 (11.3) | 48.9 (12.3) | .23a |
|
|
Triglyceride (mg/dL), median (IQR) | 120.5 (78.3-215.3) | 110.5 (68.3-165.0) | .06b |
aPaired, 2-tailed t test for parametric variables.
bWilcoxon signed-rank test for nonparametric variables.
cHbA1c: hemoglobin A1c.
dHDL: high-density lipoprotein.